BioSig Technologies (NASDAQ:BSGM) Trading 4.6% Higher

BioSig Technologies, Inc. (NASDAQ:BSGMGet Free Report) traded up 4.6% during mid-day trading on Friday . The stock traded as high as $0.34 and last traded at $0.34. 20,813 shares traded hands during trading, a decline of 96% from the average session volume of 488,961 shares. The stock had previously closed at $0.32.

BioSig Technologies Trading Up 4.6 %

The firm’s fifty day moving average is $0.43 and its 200-day moving average is $0.84.

BioSig Technologies (NASDAQ:BSGMGet Free Report) last issued its earnings results on Wednesday, August 14th. The company reported ($0.30) earnings per share (EPS) for the quarter. The business had revenue of $0.01 million for the quarter.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in BioSig Technologies stock. Armistice Capital LLC bought a new stake in BioSig Technologies, Inc. (NASDAQ:BSGMFree Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 5,600,000 shares of the company’s stock, valued at approximately $2,660,000. Armistice Capital LLC owned approximately 62.36% of BioSig Technologies at the end of the most recent quarter. 7.16% of the stock is owned by institutional investors and hedge funds.

About BioSig Technologies

(Get Free Report)

BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.

Further Reading

Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.